Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMe in MASLD-Related Cirrhosis
NCT07495995Phase 2Not yet recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Apr 2026
- Primary completion
- Dec 2030
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of S-adenosylmethionine in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Cedars-Sinai Medical Center. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
S-adenosylmethionine
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on NCT07495995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07495995.